Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.

Chronic Myeloid Leukemia (CML) affects millions worldwide, including a rising number in India. Effective management involves ...

According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Chronic Myeloid Leukemia (CML) is a type of cancer that originates in the blood-forming cells of the bone marrow and can invade the blood.

Phase II trial of the novel combination, decitabine, venetoclax, and ponatinib achieved bone marrow remission in 80% of ...

According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...

Careful management by a team of specialists is needed to balance disease control and fetal health in patients with CML who are pregnant or trying to become prengant.

For most people, the word cancer implies that there’s a tumor or mass growing somewhere in the body. However, contrary to ...

HOUSTON ― According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously ...